Kronox Lab Sciences Ltd
₹ 212
1.01%
13 Dec
- close price
About
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
Key Points
- Market Cap ₹ 787 Cr.
- Current Price ₹ 212
- High / Low ₹ 229 / 138
- Stock P/E 33.7
- Book Value ₹ 20.8
- Dividend Yield 0.24 %
- ROCE 51.5 %
- ROE 38.4 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 39.0%
Cons
- Stock is trading at 10.2 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
50 | 62 | 82 | 96 | 90 | 93 | |
39 | 48 | 63 | 74 | 62 | 62 | |
Operating Profit | 12 | 15 | 20 | 22 | 28 | 31 |
OPM % | 23% | 24% | 24% | 23% | 32% | 34% |
1 | 1 | 1 | 2 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 1 | 2 | 2 | 2 | 1 | 1 |
Profit before tax | 12 | 13 | 18 | 22 | 29 | 32 |
Tax % | 27% | 26% | 26% | 26% | 25% | |
9 | 10 | 14 | 16 | 21 | 23 | |
EPS in Rs | 343.60 | 403.73 | 565.56 | 4.42 | 5.75 | 6.28 |
Dividend Payout % | 0% | 0% | 0% | 0% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 13% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 30% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 39% |
Last Year: | 38% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 0.25 | 0.24 | 0.24 | 37 | 37 | 37 |
Reserves | 23 | 27 | 40 | 8 | 29 | 40 |
0 | 4 | 3 | 0 | 0 | 0 | |
11 | 7 | 13 | 9 | 8 | 8 | |
Total Liabilities | 34 | 38 | 57 | 54 | 74 | 85 |
6 | 9 | 11 | 16 | 26 | 26 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 2 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
29 | 28 | 45 | 38 | 47 | 57 | |
Total Assets | 34 | 38 | 57 | 54 | 74 | 85 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
4 | 11 | 9 | 20 | 17 | |
-4 | -3 | -8 | -7 | -17 | |
-0 | -7 | -1 | -13 | 0 | |
Net Cash Flow | 0 | 1 | 1 | -0 | 0 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 110 | 90 | 114 | 71 | 72 |
Inventory Days | 70 | 58 | 58 | 61 | 74 |
Days Payable | 102 | 69 | 89 | 52 | 50 |
Cash Conversion Cycle | 78 | 79 | 84 | 80 | 96 |
Working Capital Days | 100 | 100 | 128 | 83 | 143 |
ROCE % | 50% | 51% | 50% | 52% |
Documents
Announcements
-
UPDATE ON DEVELOPMENT STATUS OF UNIT-IV
13 Nov - Received approvals for construction of Unit-IV at Dahej.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Newspaper publication of unaudited financial results.
- Financial Results For The Quarter And Half Year Ended 30Th September, 2024 12 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November, 2024
12 Nov - Board approved standalone unaudited financial results.
-
Board Meeting Intimation for Considering The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2024
30 Oct - Board meeting scheduled to approve financial results.
Business Overview:[1][2]
KLSL is in High Purity Speciality Fine Chemicals Business with portfolio of about 185 products including Excipients and ingredients, High Purity Reagents, Pharmaceutical, nutraceutical and Food Chemical.